|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 156 JPY | -4.29% |
|
-2.50% | -36.84% |
SymBio Pharmaceuticals Limited reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was JPY 1,544.81 million compared to JPY 2,315.99 million a year ago. Net income was JPY 4.46 million compared to JPY 163.17 million a year ago.
Basic earnings per share from continuing operations was JPY 0.11 compared to JPY 4.25 a year ago. Diluted earnings per share from continuing operations was JPY 0.11 compared to JPY 4.18 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -36.84% | 48.22M | |
| +31.37% | 595B | |
| -2.60% | 367B | |
| +20.83% | 334B | |
| +5.69% | 289B | |
| +14.83% | 239B | |
| +9.93% | 211B | |
| -6.95% | 203B | |
| +10.77% | 171B | |
| +0.10% | 163B |
SYMBIO PHARMACEUTICALS LIMITED 